Stay updated on Cemiplimab in NSCLC: European Clinical Trial

Sign up to get notified when there's something new on the Cemiplimab in NSCLC: European Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cemiplimab in NSCLC: European Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Both screenshots show the same record history page with no substantive changes to core study details. Only minor UI labeling differences are visible.
    Difference
    0.1%
    Check dated 2026-04-02T00:45:04.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Record History now includes new additions for Study Status and Contacts/Locations (version 3.5.0, last update 2026-03-18).
    Difference
    0.5%
    Check dated 2026-03-18T18:10:10.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is added and Revision: v3.4.2 is removed, updating the page's version label.
    Difference
    0.1%
    Check dated 2026-03-11T14:47:51.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    On 2026-02-20, Contacts/Locations and Study Status were added to the study record history. On 2026-02-18, the history now shows 20 entries.
    Difference
    0.4%
    Check dated 2026-02-25T08:39:49.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added a new version entry: Revision: v3.4.2. Removed the funding-status notice and the prior Revision: v3.4.1 entry.
    Difference
    0.7%
    Check dated 2026-02-11T02:22:20.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding is now displayed. The footer revision tag has been updated from v3.4.0 to v3.4.1.
    Difference
    0.7%
    Check dated 2026-02-03T23:09:53.000Z thumbnail image

Stay in the know with updates to Cemiplimab in NSCLC: European Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cemiplimab in NSCLC: European Clinical Trial page.